 "r&d, coronavirus, vaccine, research & development")
Calls for development of a research ecosystem have been getting louder, as a consequence of the pandemic.
An expert group — comprising industry doyens, senior government officials, and academia — has submitted a detailed report to the government explaining the policy changes required to boost research and development (R&D) in the pharmaceutical space. The government had, on Tuesday, said it was temporarily allowing investments in R&D for Covid-19 drugs and vaccines as fulfilment of a company’s corporate social responsibility (CSR) obligations.
Pharma industry insiders, however, have pointed out that by limiting such collaborations to only public institutions, the Centre has limited its
